Citation: Mr. Kidd et Bm. Veale, HOW SAFE IS AUSTRALIAN GENERAL-PRACTICE AND HOW CAN IT BE MADE SAFER, Medical journal of Australia, 169(2), 1998, pp. 67-68
Citation: Ir. Cheong et Mr. Kidd, SAFE PRACTICES IN CYBERSPACE - A MEDICAL PERSPECTIVE ON COMPUTER VIRUSES, Medical journal of Australia, 166(1), 1997, pp. 44-46
Authors:
SIDDIQI AM
JENNINGS VM
KIDD MR
ACTOR JK
HUNTER RL
Citation: Am. Siddiqi et al., EVALUATION OF ELECTROCHEMILUMINESCENCE-BASED AND BIOLUMINESCENCE-BASED ASSAYS FOR QUANTITATING SPECIFIC DNA, Journal of clinical laboratory analysis, 10(6), 1996, pp. 423-431
Citation: Ps. Patterson et al., PROTECTION IN P-YOELII BLOOD-STAGE MODEL ASSOCIATED WITH TH2 TYPE CYTOKINE RESPONSE, The FASEB journal, 9(3), 1995, pp. 230-230
Citation: Rl. Hunter et al., INDUCTION OF LONG-LASTING IMMUNITY TO PLASMODIUM-YOELII MALARIA WITH WHOLE BLOOD-STAGE ANTIGENS AND COPOLYMER ADJUVANTS, The Journal of immunology, 154(4), 1995, pp. 1762-1769
Citation: Mr. Kidd et al., EVOLVING FACTOR-ANALYSIS OF SPECTROPHOTOMETRIC TITRATION - NICKEL (II)-GLYCINATE ION SYSTEM, Journal of inorganic biochemistry, 56(3), 1994, pp. 213-219
Citation: Mr. Kidd et al., EVOLVING FACTOR-ANALYSIS OF SPECTROPHOTOMETRIC TITRATION - NICKEL (II)-GLYCINATE ION SYSTEM, Journal of inorganic biochemistry, 56(3), 1994, pp. 213-219
Citation: Ca. Behling et al., INDUCTION OF PULMONARY GRANULOMAS, MACROPHAGE PROCOAGULANT ACTIVITY, AND TUMOR-NECROSIS-FACTOR-ALPHA BY TREHALOSE GLYCOLIPIDS, Annals of clinical and laboratory science, 23(4), 1993, pp. 256-266
Authors:
TENHAGEN TLM
SULZER AJ
KIDD MR
LAL AA
HUNTER RL
Citation: Tlm. Tenhagen et al., ROLE OF ADJUVANTS IN THE MODULATION OF ANTIBODY ISOTYPE, SPECIFICITY,AND INDUCTION OF PROTECTION BY WHOLE BLOOD-STAGE PLASMODIUM-YOELII VACCINES, The Journal of immunology, 151(12), 1993, pp. 7077-7085